Research in Ristimäki Lab focuses on the molecular background of gastrointestinal tumors, mainly colorectal cancer and appendix-originating pseudomyxoma peritonei. In addition to understanding the molecular aberrations behind gastrointestinal tumorigenesis, our ultimate goal is to identify novel diagnostic biomarkers and therapy targets. Besides gene and protein level changes, we also study changes concerning cellular glycosylation.
Ari Ristimäki Group
Find Out More
Our lab is part of the Applied Tumor Genomics Research Program at the Faculty of Medicine, University of Helsinki (UH). Contact information...
Colorectal Cancer Colorectal cancer (CRC) is the third most common cancer and the second most common cause of cancer death. Overall CRC is...
Cancer Foundation Finland, Finska Läkaresällskapet, Helsinki University Hospital Research Funds, Medicinska Understödsföreningen Liv och Hälsa, Sigrid Jusélius Foundation, University of Helsinki